Screening of viruses that could cause pandemics
Official title: Task A71: Comprehensive In Vivo Screening of Viral Pathogens of Pandemic Potential
Funded at Utah State University · NIH-11250870 · Data updated 2026-11-12
This study is all about finding better ways to understand and fight viral infections that could cause pandemics, so we can be more prepared and keep patients safe in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Utah State University NIH-funded |
| Lab location | 1 site (Logan, United States) |
| Project start | July 18, 2022 |
| Project end | July 17, 2025 |
| Funding year | 2025 |
| Award (this year) | $38,550 |
| NIH project number | 272201700041I-P00003-759302200002-1 |
| Project ID | NIH-11250870 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk for viral infections, particularly those related to Eastern Equine Encephalitis.
✕Less likely to help
Patients who are not at risk for viral infections or those with no history of exposure to related pathogens may not receive benefit from this research.
What this research studies
This research focuses on developing and refining models to study infectious diseases, particularly those caused by viral pathogens with the potential to lead to pandemics. By evaluating these models, researchers aim to identify and assess candidate countermeasures that could be used to combat these viruses. Patients may benefit from this research as it seeks to enhance our understanding of viral threats and improve preparedness for future outbreaks.
Why it matters
Potential benefit: If successful, this research could lead to better prevention and treatment strategies for viral infections that pose a pandemic risk.
How similar studies have gone: Other research has shown success in developing models for infectious diseases, indicating that this approach has potential for meaningful advancements.
Where this research is happening
-
Utah State University
Logan, United States Active
Researchers
- Principal investigator: Morrey, John — Utah State University
- Study coordinator: Morrey, John
Related research
Other NIH-funded projects on the same topics.
-
Advancing antiparasitic drugs for sheep, goats, and bison
A funding opportunity to develop new antiparasitic medicines for food-producing small ruminants like sheep and goats, addressing parasite resistance and limited approved options.
-
One-dose vaccine candidate for Kyasanur Forest disease (KFD) to protect people
A single-dose, live-attenuated chimeric vaccine is being developed to prevent Kyasanur Forest disease in people who may be exposed to the virus.
-
Hamster model to study hepatitis B virus infection
A researcher is creating a hamster-based model to study how hepatitis B virus infects and persists in the liver, with the goal of helping develop better treatments and cures.
-
Using social rhythm to help people with Parkinson’s talk more clearly
A small study will test whether matching someone else’s speech pace and style can help people with Parkinson’s disease speak more clearly in everyday conversations.
-
VR-SAFE: Virtual Reality Training to Help Healthcare Workers Prevent Violent Encounters
A new virtual reality training program helps healthcare workers learn skills to prevent violent encounters and stay safer on the job.
-
How bile and gut environment affect Shigella’s harmful tactics
A researcher is studying how the environment inside the gut, especially bile, changes how Shigella bacteria cause disease in people, which could lead to better treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.